Notable Thursday Option Activity: FIVN, ENPH, AEHR

Enphase Energy (ENPH) options saw 75,902 contracts traded today (≈7.6 million underlying shares), roughly 143.1% of ENPH's one‑month average daily volume (5.3M shares); the most active contract was the $43 call expiring Feb 20, 2026 with 5,574 contracts (~557,400 shares). Aehr Test Systems (AEHR) registered 12,226 options contracts (~1.2M underlying shares), about 113.6% of its one‑month ADTV (1.1M), led by the $40 call expiring Jan 15, 2027 with 3,482 contracts (~348,200 shares). The flows represent unusually high call activity and concentrated strike/expiry interest that could drive near‑term volatility and positioning in both equities, but do not convey fundamental company news.

Analysis

Market structure: The concentrated call flow in ENPH (options volume ~143% of ADV; Feb‑20‑2026 $43 notable) and AEHR (long‑dated $40 LEAPs) signals institutional demand for convex upside rather than broad retail trading. Primary beneficiaries are call buyers and any liquidity providers who delta‑hedge (forcing meaningful underlying buy flows potentially equal to hundreds of thousands of shares); short sellers and high‑gamma sellers are the immediate losers. Net effect: short‑term upward pressure on equities and implied volatility (IV) compression risk once hedges are closed, while cross‑asset spillovers are modest—slightly higher beta into solar/semicap ETFs, negligible sovereign bond and FX moves absent macro catalysts.

Risk assessment: Tail scenarios include (1) these blocks being synthetic or part of arbitrage (covered calls, convertible hedges) that flip to selling pressure when rebalanced, (2) policy/ tariff reversals affecting solar demand, and (3) earnings or supply‑chain shocks that invalidate bullish positioning. Time horizons: days—delta hedging can move price; weeks/months—IV and position roll dynamics dominate; quarters—fundamentals (module shipments, wafer fab orders) reassert. Hidden dependencies include dealer gamma exposure clustering around the $43/$40 strikes and the potential for option roll‑over into shorter expiries to amplify moves.

Trade implications: Tactical directional exposure via defined‑risk long call spreads captures dealer buy‑flow while limiting drawdowns: ENPH Feb‑2026 call spreads around the $43 strike and AEHR Jan‑2027 $40 spreads are high‑convexity plays. If front‑month IV > realized vol by >20% after the block trades, shorting premium (calendar spreads/short strangles with strict sizing) becomes attractive. Rotate small basket exposure into solar/semicap suppliers (1–3% AUM aggregate) rather than large single‑name positions to avoid idiosyncratic gamma risk.

Contrarian angle: The market is likely over‑interpreting call volume as pure directional conviction; many institutional flows are spread structures or hedges that can reverse into selling. Historical parallels (concentrated LEAP buying in highly shorted names) show a quick squeeze then mean reversion—IV collapse can punish long‑call holders. Unintended consequences: crowded long‑call positioning can produce snap losses if a single catalyst (earnings miss, policy update) triggers coordinated dealer de‑risking and heavy selling into a thin tape.

Key Decisions for Investors

• Establish a defined‑risk long in ENPH: allocate 1–1.5% AUM to buy Feb‑20‑2026 $43/$65 call spreads (buy $43 call, sell $65 call) to capture convexity from dealer delta hedging; cap loss at premium paid, take profits at +30–40% or if ENPH rallies >25% in 30 days.
• Establish a speculative LEAP spread in AEHR: allocate 0.75–1% AUM to Jan‑15‑2027 $40/$70 call spreads (buy $40, sell $70) to participate in long‑dated bullish positioning while limiting downside; hard stop if premium drops 50% or AEHR trades >30% below entry within 60 days.
• Tactically sell premium on IV dislocations: if front‑month IV for ENPH rises >20% vs 30‑day realized vol, sell 30–60 day iron condors/strangles sized ≤0.5% AUM (delta limits 0.20/0.25) and hedge with small underlying size; unwind if realized vol catches up or IV compresses by >25%.